Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (15349)	6/12/2001 3:14:43 PM
From: Cacaito	Respond to of 17367

Gw, I read most of what he said in the xoma club. No much difference than the pr report, "no sudden heart attacks" " no cancer" "no infections" xanelim is a great drug, . "but you think Amevive will get the market"... I do not remember stating so. I do remember saying long ago that xoma/DNA were ahead and Biogen "will move very aggresive" and the blue one used to say He loves competition. Well, now it seems that He is getting some of it. Either nose breaking tie or Biogen ahead (or xoma ahead!). I do remember saying xanelim was THE reason for the season and all of you were talking bpig indications. xanelim is a great drug, I own tons of DNA, sold all my Bgen but looking into it again (at least a small position), and short on xoma at $13.36 hope to get to $10 (make couple of thousands, not too greedy)and revert the position once again. Technicals,sentiments and overvaluation are against xoma in the very short term. CIBC keeps shouting as hard as it can and it keep sinking (seems CIBC is not very engage or looking for more $upport). Ok blue, I could also snore it along.